Automated Assessment of Tumor Infiltrating Lymphocytes Informs Mortality in Thin Melanoma

    S.X. Tan, Thinzar Aung, M. Claeson, C. Zhou, S. Brown, B. Acs, D. Lambie, P. Baade, N. Pandeya, H. Soyer, B. Smithers, D. Whiteman, D. Rimm, K. Khosrotehrani
    Image of study
    TLDR An automated system can predict death risk in thin melanoma by analyzing immune cells.
    The study investigated the use of an automated tumor-infiltrating lymphocyte (TIL) classification algorithm, NN192, to predict mortality in thin melanoma. The study involved a retrospective cohort of 27,660 patients with newly diagnosed thin melanoma in Queensland, Australia, and analyzed slides from 85 fatal cases and 85 paired non-fatal cases. The study found that thin melanomas in the lowest quartile of eTIL% (a metric calculated as TILs/TILs+Tumor Cells) demonstrated higher mortality (OR: 3.47; 95% CI: 1.64-7.35; p = 0.001) than tumors in the remaining quartiles. This remained true even after adjustment for anatomical location, ulceration, and mitoses (OR: 3.31; 95% CI: 1.52-7.20; p = 0.003). The study concluded that the NN192 algorithm identified an immune-cold subset of thin melanomas that independently displayed higher melanoma-specific mortality, suggesting its potential to stratify clinical management of early-stage melanoma according to patients’ risk of disease progression.
    Discuss this study in the Community →